Orthofix Medical Inc. (OFIX) is a Medical - Devices company in the Healthcare sector, currently trading at $12.72. It has a SharesGrow Score of 46/100, indicating a mixed investment profile with 1 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of OFIX = $8.29 (-34.8% from the current price, the stock appears overvalued). Analyst consensus target is OFIX = $20 (+57.2% upside).
Valuation: OFIX trades at a trailing Price-to-Earnings (P/E) of -5.3 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.1.
Financials: revenue is $822M, +24%/yr average growth. Net income is $92M (loss), growing at -207.7%/yr. Net profit margin is -11.2% (negative). Gross margin is 67.1% (-6.1 pp trend).
Balance sheet: total debt is $229M against $450M equity (Debt-to-Equity (D/E) ratio 0.51, moderate). Current ratio is 2.45 (strong liquidity). Debt-to-assets is 27%. Total assets: $851M.
Analyst outlook: 7 / 17 analysts rate OFIX as buy (41%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 58/100 (Partial), Past 0/100 (Fail), Health 50/100 (Partial), Moat 49/100 (Partial), Future 52/100 (Partial), Income 10/100 (Fail).
